ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,37632
0,48%
Bitcoin
66.176,41
-0,69%
Brent Oil
82,57
0,54%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Gpc Biotech AG ADS (MM) (GPCB)

  7. Gpc Biotech AG ADS (MM) (GPCB) Notícias

GPCB

Gpc Biotech AG ADS (MM) (GPCB)

Gpc Biotech AG ADS (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GPCB
DataHoraFonteTítuloCódigoCompanhia
21/04/200911:12Business WireNew Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACRNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/03/200903:40Business WireGPC Biotech Reports Financial Results for Fiscal Year 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
23/02/200916:17Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
17/02/200922:31Business WireGPC Biotech and Agennix Announce Proposed MergerNASDAQ:GPCBGpc Biotech AG ADS (MM)
09/12/200807:10Business WireGPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with ...NASDAQ:GPCBGpc Biotech AG ADS (MM)
13/11/200804:40Business WireGPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
06/11/200812:42Business WireGPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/08/200816:13Edgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
06/08/200819:01Business WireGPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for SatraplatinNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/07/200817:15Business WireGPC Biotech Reports That Marketing Authorization Application for Satraplatin is to Be WithdrawnNASDAQ:GPCBGpc Biotech AG ADS (MM)
12/06/200805:05Business WireGPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to TaxanesNASDAQ:GPCBGpc Biotech AG ADS (MM)
05/06/200803:49Business WireGPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
02/06/200804:06Business WireData from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial ChemotheNASDAQ:GPCBGpc Biotech AG ADS (MM)
02/06/200804:05Business WireNew Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
28/05/200804:07Business WireGPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
15/05/200803:36Business WireGPC Biotech Reports Financial Results for First Quarter 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
31/01/200816:42Edgar (US Regulatory)Gpc Biotech Ag - Amended Statement of Ownership (SC 13G/A)NASDAQ:GPCBGpc Biotech AG ADS (MM)
31/10/200701:35PR Newswire (US)GPC Biotech Today Announced Results of Survival Analysis from the SPARC TrialNASDAQ:GPCB
31/10/200701:27PR Newswire (US)Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 TrialNASDAQ:GPCB
28/09/200712:12Edgar (US Regulatory)Gpc Biotech Ag (Other) (SC 13G)NASDAQ:GPCBGpc Biotech AG ADS (MM)
23/08/200719:00PR Newswire (US)Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLPNASDAQ:GPCBGpc Biotech AG ADS (MM)
23/08/200702:58PR Newswire (US)GPC Biotech Announces RestructuringNASDAQ:GPCB
21/08/200711:41PR Newswire (US)Finkelstein Thompson LLP Announces GPC Biotech AG InvestigationNASDAQ:GPCBGpc Biotech AG ADS (MM)
08/08/200703:37PR Newswire (US)GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2007NASDAQ:GPCB
02/08/200707:05PR Newswire (US)GPC Biotech Schedules Conference Call on August 8th to Discuss First Half 2007 Financial ResultsNASDAQ:GPCB
30/07/200710:57PR Newswire (US)GPC Biotech Withdraws Satraplatin NDA Filed for Accelerated ApprovalNASDAQ:GPCB
30/07/200710:48PR Newswire (US)GPC Biotech Withdraws Satraplatin NDA For Accelerated Approval; Plans to Resubmit With Survival AnalysisNASDAQ:GPCB
27/07/200723:30PR Newswire (US)Law Offices of Howard G. Smith Announces Class Action Lawsuit Against GPC BiotechNASDAQ:GPCBGpc Biotech AG ADS (MM)
27/07/200715:05PR Newswire (US)GPC Biotech AG Named in Purported Class Action Lawsuit in the United StatesNASDAQ:GPCB
27/07/200708:00PR Newswire (US)Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines AgencyNASDAQ:GPCB
 Apresentando as notícias mais relevantes sobre:NASDAQ:GPCB

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
HBOR3
HELBOR ON
BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados